FDA Orange Book · active-ingredient family
Glucagon hydrochloride
Glucagon hydrochloride is approved in 3 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:GLUCAGON · NDA 201849
3
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable, powder
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| GLUCAGONRLD×2 | FRESENIUS KABI USA | NDA 201849 | — | May 08, 2015 | |
| GLUCAGENRLD×2 | NOVO NORDISK | NDA 020918 | — | Jun 22, 1998 | |
| GLUCAGONRLD×2 | LILLY | NDA 012122 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Glucagon hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

